Clinical trial
BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System
NCT02880618 is registered in ClinicalTrials.gov with CVRx, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction: A Post-Market Registry With the CE-Marked BAROSTIM NEO™ System
- Lead sponsor
- CVRx, Inc.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 13, 2016
- Completion date
- July 31, 2027
- Enrollment
- 500 (estimated)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.